The Development of a Protocol for the Use of 5–HT3 Antagonists in Chemotherapy-Induced Nausea and Vomiting

J. Watters^*, M. Riley, I. Pedley, A. Whitehead, M. Overend, I. Goss, V. Allgar

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{ecf8652ae4ac445fb1a44532eaeba6ff,

title = "The Development of a Protocol for the Use of 5–HT3 Antagonists in Chemotherapy-Induced Nausea and Vomiting",

author = "J. Watters and M. Riley and I. Pedley and A. Whitehead and M. Overend and I. Goss and V. Allgar",

year = "2001",

month = dec,

doi = "10.1053/clon.2001.9305",

language = "English",

volume = "13",

pages = "422--426",

journal = "Clinical Oncology",

issn = "0936-6555",

publisher = "W.B. Saunders Ltd",

number = "6",

}

TY - JOUR

T1 - The Development of a Protocol for the Use of 5–HT3 Antagonists in Chemotherapy-Induced Nausea and Vomiting

AU - Watters, J.

AU - Riley, M.

AU - Pedley, I.

AU - Whitehead, A.

AU - Overend, M.

AU - Goss, I.

AU - Allgar, V.

PY - 2001/12

Y1 - 2001/12

U2 - 10.1053/clon.2001.9305

DO - 10.1053/clon.2001.9305

M3 - Article

SN - 0936-6555

VL - 13

SP - 422

EP - 426

JO - Clinical Oncology

JF - Clinical Oncology

IS - 6

ER -